C型肝炎ウイルス研究のこれまでと今後の課題

2020年のノーベル医学生理学賞はC型肝炎とその原因ウイルス発見,病態解明に貢献のあった3研究者に送られた.これら受賞対象研究を経て,C型肝炎ウイルス(HCV)のウイルス学的技術や実験手法は大きく改善され,その後効果的な抗ウイルス治療も確立され,まさにHCV研究は円熟期を迎えている.本総説では,これまでのHCV研究の流れをおさらいし,今後のHCV研究の課題に触れながら,私たちがおこなっているHCV培養系を利用した生理活性天然物探索研究を紹介する....

Full description

Saved in:
Bibliographic Details
Published inウイルス Vol. 70; no. 2; pp. 129 - 134
Main Author 渡士, 幸一
Format Journal Article
LanguageJapanese
Published 日本ウイルス学会 2020
Online AccessGet full text
ISSN0042-6857
1884-3433
DOI10.2222/jsv.70.129

Cover

Abstract 2020年のノーベル医学生理学賞はC型肝炎とその原因ウイルス発見,病態解明に貢献のあった3研究者に送られた.これら受賞対象研究を経て,C型肝炎ウイルス(HCV)のウイルス学的技術や実験手法は大きく改善され,その後効果的な抗ウイルス治療も確立され,まさにHCV研究は円熟期を迎えている.本総説では,これまでのHCV研究の流れをおさらいし,今後のHCV研究の課題に触れながら,私たちがおこなっているHCV培養系を利用した生理活性天然物探索研究を紹介する.
AbstractList 2020年のノーベル医学生理学賞はC型肝炎とその原因ウイルス発見,病態解明に貢献のあった3研究者に送られた.これら受賞対象研究を経て,C型肝炎ウイルス(HCV)のウイルス学的技術や実験手法は大きく改善され,その後効果的な抗ウイルス治療も確立され,まさにHCV研究は円熟期を迎えている.本総説では,これまでのHCV研究の流れをおさらいし,今後のHCV研究の課題に触れながら,私たちがおこなっているHCV培養系を利用した生理活性天然物探索研究を紹介する.
Author 渡士, 幸一
Author_xml – sequence: 1
  fullname: 渡士, 幸一
  organization: 国立感染症研究所ウイルス第二部
BookMark eNo9T0tLw0AYXKSCsfbi_0jc7MPdHHqQ4AsKXvQcdpMv2lCrJEXwmPWmxYteFQXxCT14EETon1lL6r8wojiHGWYOM8w8avQP-oDQoo89UmMpK448gT2fBDPI8aVkLmWUNpCDMSPusuRiDrWKoqsxxgEPJOEOaoeT67OpuarMuTX31tzZkxdr3quby-rpzZYjW15YM7Tl2JYPtnz8_DidjGs7mj6_ft0OF9BsqnoFtP60iXbWVrfDDbeztb4ZrnTcjBApXYJlSupNSTXoIGYSEsBcpj6nmiQqDYgEATrRWPJUc1CMKhFDIFIGoDDQJmr_9mbFQO1CdJh391V-HKl80I17ENXPI4Ej8kP1_f883lN5lCn6DSC_apY
ContentType Journal Article
DOI 10.2222/jsv.70.129
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1884-3433
EndPage 134
ExternalDocumentID article_jsv_70_2_70_129_article_char_ja
GroupedDBID 2WC
ABJNI
ACGFS
ACPRK
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
F5P
JSF
KQ8
OK1
RJT
ID FETCH-LOGICAL-j2288-208f200983beb9c48ede058f153b2daf928e7ebdb085fb5ea43a7ce97f4eea0e3
ISSN 0042-6857
IngestDate Wed Sep 03 06:30:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2288-208f200983beb9c48ede058f153b2daf928e7ebdb085fb5ea43a7ce97f4eea0e3
OpenAccessLink https://www.jstage.jst.go.jp/article/jsv/70/2/70_129/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_jsv_70_2_70_129_article_char_ja
PublicationCentury 2000
PublicationDate 2020
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – year: 2020
  text: 2020
PublicationDecade 2020
PublicationTitle ウイルス
PublicationTitleAlternate ウイルス
PublicationYear 2020
Publisher 日本ウイルス学会
Publisher_xml – name: 日本ウイルス学会
References 8)Pawlotsky JM. Interferon-Free Hepatitis C Virus Therapy. Cold Spring Harb Perspect Med 2020;10.
11)Kanda Y, Yamasaki Y, Shimura S, et al. MA026, an anti-hepatitis C virus compound, opens tight junctions of the epithelial cell membrane. J Antibiot (Tokyo) 2017;70:691-694.
12)Nakajima S, Watashi K, Ohashi H, et al. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. J Virol 2016;90:9058-74.
5)Kolykhalov AA, Agapov EV, Blight KJ, et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997;277:570-4.
3)Kolykhalov AA, Feinstone SM, Rice CM. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol 1996;70:3363-71.
6)Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-3.
2)Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
7)Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-6.
9)Shin EC, Han JW, Kang W, et al. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses. Viruses 2020;12.
13)Nakajima S, Watashi K, Kamisuki S, et al. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. Biochem Biophys Res Commun 2013;440:515-20.
14)Nishikori S, Takemoto K, Kamisuki S, et al. Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei. J Nat Prod 2016;79:442-6.
1)Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
4)Tanaka T, Kato N, Cho MJ, et al. Structure of the 3' terminus of the hepatitis C virus genome. J Virol 1996; 70:3307-12.
10)Shimura S, Ishima M, Nakajima S, et al. Total synthesis and anti-hepatitis C virus activity of MA026. J Am Chem Soc 2013;135:18949-56.
15)Watanabe R, Mizoguchi H, Oikawa H, et al. Stereo-controlled synthesis of functionalized tetrahydropyridines based on the cyanomethylation of 1,6-dihydropyridines and generation of anti-hepatitis C virus agents. Bioorg Med Chem 2017;25:2851-2855.
References_xml – reference: 4)Tanaka T, Kato N, Cho MJ, et al. Structure of the 3' terminus of the hepatitis C virus genome. J Virol 1996; 70:3307-12.
– reference: 6)Lohmann V, Korner F, Koch J, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-3.
– reference: 14)Nishikori S, Takemoto K, Kamisuki S, et al. Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei. J Nat Prod 2016;79:442-6.
– reference: 11)Kanda Y, Yamasaki Y, Shimura S, et al. MA026, an anti-hepatitis C virus compound, opens tight junctions of the epithelial cell membrane. J Antibiot (Tokyo) 2017;70:691-694.
– reference: 8)Pawlotsky JM. Interferon-Free Hepatitis C Virus Therapy. Cold Spring Harb Perspect Med 2020;10.
– reference: 13)Nakajima S, Watashi K, Kamisuki S, et al. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. Biochem Biophys Res Commun 2013;440:515-20.
– reference: 9)Shin EC, Han JW, Kang W, et al. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses. Viruses 2020;12.
– reference: 2)Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
– reference: 3)Kolykhalov AA, Feinstone SM, Rice CM. Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol 1996;70:3363-71.
– reference: 15)Watanabe R, Mizoguchi H, Oikawa H, et al. Stereo-controlled synthesis of functionalized tetrahydropyridines based on the cyanomethylation of 1,6-dihydropyridines and generation of anti-hepatitis C virus agents. Bioorg Med Chem 2017;25:2851-2855.
– reference: 1)Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
– reference: 5)Kolykhalov AA, Agapov EV, Blight KJ, et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997;277:570-4.
– reference: 12)Nakajima S, Watashi K, Ohashi H, et al. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System. J Virol 2016;90:9058-74.
– reference: 10)Shimura S, Ishima M, Nakajima S, et al. Total synthesis and anti-hepatitis C virus activity of MA026. J Am Chem Soc 2013;135:18949-56.
– reference: 7)Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-6.
SSID ssib000959825
ssib002809730
ssib007290146
ssib058494566
ssj0038190
ssib000972806
ssib002821791
Score 2.2317502
Snippet 2020年のノーベル医学生理学賞はC型肝炎とその原因ウイルス発見,病態解明に貢献のあった3研究者に送られた.これら受賞対象研究を経て,C型肝炎ウイルス(HCV)のウイルス...
SourceID jstage
SourceType Publisher
StartPage 129
Title C型肝炎ウイルス研究のこれまでと今後の課題
URI https://www.jstage.jst.go.jp/article/jsv/70/2/70_129/_article/-char/ja
Volume 70
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX ウイルス, 2020, Vol.70(2), pp.129-134
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1884-3433
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0038190
  issn: 0042-6857
  databaseCode: KQ8
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1884-3433
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0038190
  issn: 0042-6857
  databaseCode: DIK
  dateStart: 19580101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Ni9UwMDxWBC_iJ36zB3Ps2pembXLwkHYri6Ag7MLeSvOaHt5hFfetoLdXb7p40auiIH7CHjwIIuyfqctbf4XONG23iofnXsI0mSaZzCSZyceEkKsFuqHTI-0IyXOH68x3dAg2j-Z5wSFF-_UO_q3bwcoav7nurw8Gv3qnlrYmemn06J_3Sg7DVYgDvuIt2f_gbJcpRAAM_IUQOAzhXDyOaeJTmVAR0URQwahcpkmIgEho4iGgghbgNeBRFTUxkURk5VLJa0DSyCIPqUoaQHoNsoibmKhNUmELCJpwGkVUKKwPIHTImI-gStGI0URSNYSkvjo8TyVbkaBJQCOBeUAhqkYB8ahLlJiAdYBGcPvrGMztZA5_l0ClXwMxVfF8LQRlLdc4kH1MpeoP85w5gbCer5eMHdmF4I7HrdeNdui3b5Y0Is564_iwWYaxKsHQrrf-PduAaoXea8ebD5ZCdNMhD-bU7qRjIxspIKWhmzIMADNt4_FuXToGBf8IwwUlPFVwp6cfS_Sv2Lc38TWxP7bFZdiz_8B-Rnez3XdY75J3-KBsSl7r71ZVQWu9u6OF7WX99yJd1w6oAt1sDJZKe8qxVrxWT5DjjcW0qCwpJ8lgnJ0iR-0bqg9Pk-vx3qun--XLWfmsKt9V5dvq8eeq_DZ7_WL28Ws13ammz6tyu5ruVtP31fTDj-9P9nbhc2f_05efb7bPkLUbyWq84jRvgjhjxuruLwrc0BOeNlqOuDC5AboKmLg1y7NCMmFCo3MNpkShfZNxLwtHRoYFNyZzjXeWLGzc3TDnyKIfhpmnwcQR7ogHQoDtIXKZF4Ur2Uj42XkSWLrTe9bxSzonMy8c9seL5Bj2DLvCd4ksTO5vmcug8070lVoufgPOlo6g
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=C%E5%9E%8B%E8%82%9D%E7%82%8E%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9%E7%A0%94%E7%A9%B6%E3%81%AE%E3%81%93%E3%82%8C%E3%81%BE%E3%81%A7%E3%81%A8%E4%BB%8A%E5%BE%8C%E3%81%AE%E8%AA%B2%E9%A1%8C&rft.jtitle=%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9&rft.au=%E6%B8%A1%E5%A3%AB%2C+%E5%B9%B8%E4%B8%80&rft.date=2020&rft.pub=%E6%97%A5%E6%9C%AC%E3%82%A6%E3%82%A4%E3%83%AB%E3%82%B9%E5%AD%A6%E4%BC%9A&rft.issn=0042-6857&rft.eissn=1884-3433&rft.volume=70&rft.issue=2&rft.spage=129&rft.epage=134&rft_id=info:doi/10.2222%2Fjsv.70.129&rft.externalDocID=article_jsv_70_2_70_129_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0042-6857&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0042-6857&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0042-6857&client=summon